CD7 (T-Cell Leukemia Marker)(HuLy-m2) , Biotin conjugate , 0.1mg / mL
Recognizes a protein of 40 kDa , identified as CD7 (Workshop IV; Code T165). CD7 is a member of the immunoglobulin gene superfamily. Its N-terminal amino acids 1-107 are highly homologous to Ig kappa-L chains whereas the carboxyl-terminal region of the extracellular domain is proline-rich and has been postulated to form a stalk from which the Ig domain projects. CD7 is expressed on the majority of immature and mature T-lymphocytes , and T cell leukemia. It is also found on natural killer cells , a small subpopulation of normal B cells and on malignant B cells. Cross-linking surface CD7 positively modulates T cell and NK cell activity as measured by calcium fluxes , expression of adhesion molecules , cytokine secretion and proliferation. CD7 associates directly with phosphoinositol 3'-kinase. CD7 ligation induces production of D-3 phosphoinositides and tyrosine phosphorylation.
Référence interne:
BNCB1252-100
URL de site web:
/shop/bncb1252-100-cd7-t-cell-leukemia-marker-huly-m2-biotin-conjugate-0-1mg-ml-195782